Trotta Matteo 4

What Happened
Matteo Trotta, EVP and GM, Dermatology US at Incyte (INCY), had 537 shares withheld on March 25, 2026 to satisfy tax withholding obligations tied to the settlement of previously reported restricted stock units (RSUs). The withheld shares were valued at $92.23 each, for a total of approximately $49,528. This was a tax-withholding disposal (code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-03-25; price per share: $92.23; shares withheld/disposed: 537; total value ≈ $49,528.
• Transaction type: F — shares withheld automatically to satisfy tax withholding on RSU settlement (cashless/tax-withholding disposition).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote F1: withholding was automatic by the issuer to meet tax obligations at RSU settlement.
• Footnote F2: filing notes an aggregate of 11,160 shares issuable under previously reported RSUs that have not vested.
• Filing date: 2026-03-26 (filed the day after the transaction); this appears timely under standard Form 4 reporting rules.

Context
Withholdings to cover taxes on vested RSUs are routine and do not signal a purchase decision or an independent decision to sell shares in the market. For retail investors, this transaction is administrative in nature — it reduces Trotta’s outstanding shares by the withheld amount but does not imply a view on Incyte’s stock.